BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Alharthi J, Latchoumanin O, George J, Eslam M. Macrophages in metabolic associated fatty liver disease. World J Gastroenterol 2020; 26(16): 1861-1878 [PMID: 32390698 DOI: 10.3748/wjg.v26.i16.1861]
URL: https://www.wjgnet.com/1007-9327/full/v26/i16/1861.htm
Number Citing Articles
1
Zhao-Chun Chi. Progress in understanding of association between metabolic associated fatty liver disease and viral infectious diseasesWorld Chinese Journal of Digestology 2022; 30(18): 783 doi: 10.11569/wcjd.v30.i18.783
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
2
Jingqi Liu, Yang Song, Ye Wang, Huashan Hong. Vitamin D/vitamin D receptor pathway in non-alcoholic fatty liver diseaseExpert Opinion on Therapeutic Targets 2023; 27(11): 1145 doi: 10.1080/14728222.2023.2274099
3
Ziyan Pan, Saleh A. Alqahtani, Mohammed Eslam. MAFLD and chronic kidney disease: two sides of the same coin?Hepatology International 2023; 17(3): 519 doi: 10.1007/s12072-023-10526-9
4
Eleni-Myrto Trifylli, Anastasios G. Kriebardis, Evangelos Koustas, Nikolaos Papadopoulos, Melanie Deutsch, Georgios Aloizos, Sotirios P. Fortis, Effie G. Papageorgiou, Ariadne Tsagarakis, Spilios Manolakopoulos. The Emerging Role of Extracellular Vesicles and Autophagy Machinery in NASH—Future Horizons in NASH ManagementInternational Journal of Molecular Sciences 2022; 23(20): 12185 doi: 10.3390/ijms232012185
5
Luca Miele, Cecilia Napodano, Alfredo Cesario, Antonio De Magistris, Krizia Pocino, Umberto Basile, Gian L. Rapaccini, Antonio Gasbarrini, Antonio Grieco. COVID‐19, adaptative immune response and metabolic‐associated liver diseaseLiver International 2021; 41(11): 2560 doi: 10.1111/liv.15061
6
Fangshuo Jiang, Ye Peng, Quancai Sun. Pesticides exposure induced obesity and its associated diseases: recent progress and challengesJournal of Future Foods 2022; 2(2): 119 doi: 10.1016/j.jfutfo.2022.03.005
7
Shanshan Liu, Jialu Wang, Shujing Wu, Jingya Niu, Ruizhi Zheng, Lizhan Bie, Zhuojun Xin, Shuangyuan Wang, Hong Lin, Zhiyun Zhao, Tiange Wang, Min Xu, Jieli Lu, Yuhong Chen, Yiping Xu, Weiqing Wang, Guang Ning, Yufang Bi, Mian Li, Yu Xu. The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysisMetabolism 2021; 120: 154779 doi: 10.1016/j.metabol.2021.154779
8
Nahum Méndez‐Sánchez, Jian‐Gao Fan, Mohamed El‐Kassas, Marcos Girala. MAFLD: A quick fact checkLiver International 2022; 42(12): 2903 doi: 10.1111/liv.15422
9
Xiaoqin Zhu, Chuanfei Zeng, Baoping Yu. White adipose tissue in metabolic associated fatty liver diseaseClinics and Research in Hepatology and Gastroenterology 2024; 48(5): 102336 doi: 10.1016/j.clinre.2024.102336
10
Chun-Liang Chen, Yu-Cheng Lin. Autophagy Dysregulation in Metabolic Associated Fatty Liver Disease: A New Therapeutic TargetInternational Journal of Molecular Sciences 2022; 23(17): 10055 doi: 10.3390/ijms231710055
11
Yongliang Chang, Xiawei Wu, Shengwei Lu, Jiahao Du, Yixiu Long, Yefei Zhu, Huanlong Qin. Engineered procyanidin-Fe nanoparticle alleviates intestinal inflammation through scavenging ROS and altering gut microbiome in colitis miceFrontiers in Chemistry 2023; 11 doi: 10.3389/fchem.2023.1089775
12
Joselyn N. Allen, Adwitia Dey, Jingwei Cai, Jingtao Zhang, Yuan Tian, Mary Kennett, Yanling Ma, T. Jake Liang, Andrew D. Patterson, Pamela A. Hankey-Giblin. Metabolic Profiling Reveals Aggravated Non-Alcoholic Steatohepatitis in High-Fat High-Cholesterol Diet-Fed Apolipoprotein E-Deficient Mice Lacking Ron Receptor SignalingMetabolites 2020; 10(8): 326 doi: 10.3390/metabo10080326
13
Gabriel Tayguara Silveira Guerreiro, Larisse Longo, Mariana Alves Fonseca, Valessa Emanoele Gabriel de Souza, Mário Reis Álvares-da-Silva. Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?Hepatology International 2021; 15(2): 380 doi: 10.1007/s12072-021-10157-y
14
Yiming Cao, Xiaoxue Fang, Mingyang Sun, Yegang Zhang, Mengyao Shan, Xintian Lan, Difu Zhu, Haoming Luo. Preventive and therapeutic effects of natural products and herbal extracts on nonalcoholic fatty liver disease/nonalcoholic steatohepatitisPhytotherapy Research 2023; 37(9): 3867 doi: 10.1002/ptr.7932
15
Allah Nawaz, Azhar Manzoor, Saeed Ahmed, Naveed Ahmed, Waseem Abbas, Mushtaq Ahmad Mir, Muhammad Bilal, Alisha Sheikh, Saleem Ahmad, Ishtiaq Jeelani, Takashi Nakagawa. Therapeutic approaches for chronic hepatitis C: a concise reviewFrontiers in Pharmacology 2024; 14 doi: 10.3389/fphar.2023.1334160
16
Amr Ahmed El-Arabey, Mohnad Abdalla. GATA3 as an immunomodulator in obesity-related metabolic dysfunction associated with fatty liver disease, insulin resistance, and type 2 diabetesChemico-Biological Interactions 2022; 366: 110141 doi: 10.1016/j.cbi.2022.110141
17
Yiyuan Zheng, Dan Fang, Chaoyuan Huang, Lina Zhao, Liming Gan, Youlan Chen, Fengbin Liu. Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver DiseaseFrontiers in Pharmacology 2022; 12 doi: 10.3389/fphar.2021.816032
18
Jawaher Alharthi, Mohammed Eslam. Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An UpdateJournal of Clinical and Translational Hepatology 2022; 10(1): 134 doi: 10.14218/JCTH.2021.00248
19
Jiaxuan Wu, Jiashu Pan, Wenjun Zhou, Guang Ji, Yanqi Dang. The role of N6-methyladenosine in macrophage polarization: A novel treatment strategy for non-alcoholic steatohepatitisBiomedicine & Pharmacotherapy 2024; 171: 116145 doi: 10.1016/j.biopha.2024.116145
20
Waleed Alghamdi, Mahmoud Mosli, Saleh A. Alqahtani. Gut microbiota in MAFLD: therapeutic and diagnostic implicationsTherapeutic Advances in Endocrinology and Metabolism 2024; 15 doi: 10.1177/20420188241242937
21
Lili Yu, Wei Hong, Shen Lu, Yanrong Li, Yaya Guan, Xiaogang Weng, Zhiwei Feng. The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and TreatmentFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.780496
22
Sahil Khanna, Neal S. Parikh, Lisa B. VanWagner. Fatty liver and cerebrovascular disease: plausible association and possible mechanismsCurrent Opinion in Lipidology 2022; 33(1): 31 doi: 10.1097/MOL.0000000000000799
23
Nicolas Lanthier, Valérie Lebrun, Olivier Molendi-Coste, Nico van Rooijen, Isabelle A. Leclercq. Liver Fetuin-A at Initiation of Insulin ResistanceMetabolites 2022; 12(11): 1023 doi: 10.3390/metabo12111023
24
Anika Niambi Al-Shura. Metabolic Disorders and Shen in Integrative Cardiovascular Chinese Medicine2021; : 17 doi: 10.1016/B978-0-12-818922-1.00003-9
25
Amit Khurana, Umashanker Navik, Prince Allawadhi, Poonam Yadav, Ralf Weiskirchen. Spotlight on liver macrophages for halting liver disease progression and injuryExpert Opinion on Therapeutic Targets 2022; 26(8): 707 doi: 10.1080/14728222.2022.2133699
26
María Crespo, Ivana Nikolic, Alfonso Mora, Elena Rodríguez, Luis Leiva‐Vega, Aránzazu Pintor‐Chocano, Daniel Horrillo, Lourdes Hernández‐Cosido, Jorge L. Torres, Eva Novoa, Rubén Nogueiras, Gema Medina‐Gómez, Miguel Marcos, Magdalena Leiva, Guadalupe Sabio. Myeloid p38 activation maintains macrophage–liver crosstalk and BAT thermogenesis through IL‐12–FGF21 axisHepatology 2023; 77(3): 874 doi: 10.1002/hep.32581
27
Gao-Xin Xu, Song Wei, Chao Yu, Si-Qi Zhao, Wei-Jun Yang, Yong-Heng Feng, Chao Pan, Kun-Xing Yang, Yong Ma. Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventionsFrontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1199519
28
Yu Jung Heo, Sung‐E Choi, Nami Lee, Ja Young Jeon, Seung Jin Han, Dae Jung Kim, Yup Kang, Kwan Woo Lee, Hae Jin Kim. Visfatin exacerbates hepatic inflammation and fibrosis in a methionine‐choline‐deficient diet mouse modelJournal of Gastroenterology and Hepatology 2021; 36(9): 2592 doi: 10.1111/jgh.15465
29
Fang Lei, Xiao-Ming Wang, Changquan Wang, Xuewei Huang, Ye-Mao Liu, Juan-Juan Qin, Peng Zhang, Yan-Xiao Ji, Zhi-Gang She, Jingjing Cai, Huo-ping Li, Xiao-Jing Zhang, Hongliang Li. Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in ChinaFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1109673
30
Fan Yang, Ping Huang, Liandong Shi, Feng Liu, Aimei Tang, Shaohui Xu. <p>Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice</p>Drug Design, Development and Therapy 2020; : 3865 doi: 10.2147/DDDT.S258857
31
Lei Liu, Changfa Wang, Shuwen Deng, Ting Yuan, Xiaoling Zhu, Yuling Deng, Yuexiang Qin, Yaqin Wang, Pingting Yang. Transition patterns of metabolic dysfunction-associated fatty liver disease status in relation to arterial stiffness progression: a health check-up cohort studyScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-35733-0
32
Jawaher Alharthi, Ali Bayoumi, Khaled Thabet, Ziyan Pan, Brian S. Gloss, Olivier Latchoumanin, Mischa Lundberg, Natalie A. Twine, Duncan McLeod, Shafi Alenizi, Leon A. Adams, Martin Weltman, Thomas Berg, Christopher Liddle, Jacob George, Mohammed Eslam. A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomesNature Communications 2022; 13(1) doi: 10.1038/s41467-022-35158-9
33
Jinfan Liu, Weizhao Li, Yangping Bian, Xiaoqing Jiang, Fuyun Zhu, Fei Yin, Li Yin, Xiaomei Song, Hong Guo, Jianhui Liu. Garlic-derived exosomes regulate PFKFB3 expression to relieve liver dysfunction in high-fat diet-fed mice via macrophage-hepatocyte crosstalkPhytomedicine 2023; 112: 154679 doi: 10.1016/j.phymed.2023.154679
34
Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Manuel Romero-Gómez, Mohammed Eslam, Nahum Méndez-Sánchez. Metabolic dysfunction: The silenced connection with fatty liver diseaseAnnals of Hepatology 2023; 28(6): 101138 doi: 10.1016/j.aohep.2023.101138
35
Tae Kyung Yoo, Seung Wook Lee, Mi Yeon Lee, Hanna Choi, Ki-Chul Sung. Influence of MAFLD and NAFLD on arterial stiffness: A longitudinal cohort studyNutrition, Metabolism and Cardiovascular Diseases 2024;  doi: 10.1016/j.numecd.2024.03.008
36
Sherine Ahmed Elsherif, Ahmed Salah Alm. Role of macrophages in liver cirrhosis: fibrogenesis and resolutionAnatomy & Cell Biology 2022; 55(1): 14 doi: 10.5115/acb.21.046
37
Ziyan Pan, Rasha El Sharkway, Ali Bayoumi, Mayada Metwally, Brian S. Gloss, Robert Brink, David Bo Lu, Christopher Liddle, Saleh A. Alqahtani, Jun Yu, Philip J. O’Connell, Jacob George, Mohammed Eslam. Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic diseaseScience Translational Medicine 2024; 16(741) doi: 10.1126/scitranslmed.adj0133
38
Jawaher Alharthi, Ziyan Pan, Brian S. Gloss, Duncan McLeod, Martin Weltman, Jacob George, Mohammed Eslam. Loss of metabolic adaptation in lean MAFLD is driven by endotoxemia leading to epigenetic reprogrammingMetabolism 2023; 144: 155583 doi: 10.1016/j.metabol.2023.155583
39
Mikkel Breinholt Kjær, Jacob George, Konstantin Kazankov, Henning Grønbæk. Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy?Expert Review of Gastroenterology & Hepatology 2021; 15(1): 51 doi: 10.1080/17474124.2020.1817740
40
Yangping Bian, Weizhao Li, Xiaoqing Jiang, Fei Yin, Li Yin, Yonglan Zhang, Hong Guo, Jianhui Liu. Garlic-derived exosomes carrying miR-396e shapes macrophage metabolic reprograming to mitigate the inflammatory response in obese adipose tissueThe Journal of Nutritional Biochemistry 2023; 113: 109249 doi: 10.1016/j.jnutbio.2022.109249